Advarra

AUGUST 31, 2022

Injuries from sharps in a research or clinical setting are a serious problem for employees, as the CDC estimates almost 400,000 needlesticks and other sharps-related injuries occur to healthcare personnel each year. All potentially infectious sharps must be disposed of in a biohazard sharps container immediately after use without recapping.

Production 52

Production Biohazard Biohazard Containment 52

Advarra

JULY 28, 2022

This article explores how these tools work and why biosafety cabinets are preferred in research involving cell and gene therapies. Why Does the IBC Prefer Researchers use a Biosafety Cabinet vs a Clean Bench? In the case of IBC review, we’re preventing exposure to biologics such as engineered genetic materials and/or infectious agents.

Contamination 52

Contamination Biohazard Biohazard Production 52

Advarra

OCTOBER 26, 2023

Controlled Environment and IP Containment The potential for a release, and the risk associated with a genetically engineered IP, are part of the IBC’s assessment purview under National Institutes of Health (NIH) Guidelines. And don’t forget to affix a biohazard sticker to the exterior for quick and clear identification.

Production 52

Production Containment Biohazard Biohazard 52

Advarra

JUNE 12, 2023

Gene therapy research is exciting and full of promise, but because of the risks involved, it’s also highly regulated, requiring an institutional biosafety committee (IBC) to provide additional oversight and risk assessment. IRBs are tasked with protecting research subject’s rights and welfare. What Does an IBC Review?

Genetic Engineering 98

Genetic Engineering Gene Therapy Genetics Engineer 98